Full Text
EE271 Cost-Effectiveness Analysis of RSVPreF3 OA Vaccine for Adults 60 Years or Older in Austria

Abstract

Authors

L Zarkadoulas G Uhl H Rouha

Back to Volume 27, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×